RxSight, Inc.
NASDAQ:RXST
33.66 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -48.608 | -66.756 | -48.688 | 27.575 | 126.22 |
Depreciation & Amortization
| 4.243 | 4.022 | 3.988 | 4.012 | 3.93 |
Deferred Income Tax
| 0 | 0 | -5.398 | -63.212 | 0 |
Stock Based Compensation
| 15.746 | 11.397 | 7.575 | 4.185 | 4.598 |
Change In Working Capital
| -9.072 | -7.412 | -2.678 | -7.848 | -3.971 |
Accounts Receivables
| -9.325 | -6.094 | -1.996 | -2.076 | -0.789 |
Inventory
| -2.749 | -7.555 | -2.111 | -1.307 | -5.471 |
Accounts Payables
| 1.25 | 0.635 | 0.555 | -0.954 | 1.133 |
Other Working Capital
| 1.752 | 5.602 | 0.874 | -3.511 | 1.156 |
Other Non Cash Items
| -3.902 | -0.101 | 0.493 | 0.085 | -171.396 |
Operating Cash Flow
| -41.593 | -58.85 | -44.708 | -35.203 | -40.619 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -4.814 | -2.393 | -1.94 | -2.539 | -4.086 |
Acquisitions Net
| 17.315 | -42.343 | 79.967 | 0.003 | 0.603 |
Purchases Of Investments
| -272.315 | -212.657 | -159.967 | -97.873 | -132.387 |
Sales Maturities Of Investments
| 255 | 255 | 80 | 116 | 130 |
Other Investing Activites
| -17.315 | 42.343 | -79.967 | 18.13 | -1.784 |
Investing Cash Flow
| -22.129 | 39.95 | -81.907 | 15.591 | -5.87 |
Financing Activities: | |||||
Debt Repayment
| -40.153 | -0.121 | 14.973 | 24.858 | -0.185 |
Common Stock Issued
| 105.957 | 7.828 | 121.136 | 1.015 | 1.591 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -4.28 | -1.375 | 1.233 | 0.379 | 1.515 |
Financing Cash Flow
| 61.524 | 6.332 | 137.342 | 25.237 | 1.33 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0.006 | -0.009 | -0.01 | 0 | 0.005 |
Net Change In Cash
| -2.192 | -12.577 | 10.717 | 5.625 | -45.154 |
Cash At End Of Period
| 10.403 | 12.595 | 25.172 | 14.455 | 8.83 |